Skip to main content
Premium Trial:

Request an Annual Quote

Andrew Mignatti

Perthera announced that Andrew Mignatti has joined the firm as CEO. Mignatti joins Perthera from RedPath, where he served as senior VP of operations. Mignatti also previously worked with Esoterix and Laboratory Corporation of America and has more than 15 years of experience in the pathology, laboratory, and diagnostic fields. Mignatti is a graduate of Saint Edward University in Austin, Texas.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more